Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Citalopram hydrobromide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Citalopram 20mg tablets
0403030D0AAAAAA
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | 1,174,009 |
|
Citalopram 10mg tablets
0403030D0AAABAB
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | 637,955 |
|
Citalopram 40mg tablets
0403030D0AAACAC
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | 403,624 |
|
Citalopram 20mg/5ml oral suspension
0403030D0AAADAD
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | 3 |
|
Citalopram 10mg/5ml oral suspension
0403030D0AAAGAG
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | No data available |
|
Citalopram 30mg tablets
0403030D0AAAMAM
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.